Imetelstat as a novel therapeutic approach for myelodysplastic syndrome

Imetelstat as a novel therapeutic approach for myelodysplastic syndrome

Saved in:

Bibliographic Details
Main Authors:	Ammara Waheed Arain, Anushka Andani, Aayat Kashif, Radeyah Waseem
Format:	Article
Language:	English
Published:	Elsevier 2025-01-01
Series:	Hematology, Transfusion and Cell Therapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2531137924028396
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Myelodysplastic Syndrome and Autoimmunity: A Case Report of an Unusual Presentation of Myelodysplastic Syndrome
by: Andrea L. Merrill, et al.
Published: (2011-01-01)

Transfusion Thresholds, Quality of Life, and Current Approaches in Myelodysplastic Syndromes
by: Ioannis Koutsavlis
Published: (2016-01-01)

Sweet Syndrome due to Myelodysplastic Syndrome: Possible Therapeutic Role of Intravenous Immunoglobulin in Addition to Standard Treatment
by: Harry H. S. Gill, et al.
Published: (2010-01-01)

Iron Chelation Therapy in Myelodysplastic Syndromes
by: Emanuela Messa, et al.
Published: (2010-01-01)

Acquired Myelodysplasia or Myelodysplastic Syndrome: Clearing the Fog
by: Ethan A. Natelson, et al.
Published: (2013-01-01)

Mimicking Myelodysplastic Syndrome: Importance of Differential Diagnosis
by: Thomas Luo, et al.
Published: (2021-01-01)

Myelodysplastic Syndrome with Transfusion Dependence Treated with Venetoclax
by: Waqas Jehangir, et al.
Published: (2020-01-01)

Monocyte-Derived Macrophages Are Impaired in Myelodysplastic Syndrome
by: Yu Han, et al.
Published: (2016-01-01)

Rothia mucilaginosa Meningitis in a Child with Myelodysplastic Syndromes
by: Fumihiro Ochi, et al.
Published: (2021-01-01)

The molecular prognostic scoring system for normal karyotype myelodysplastic syndromes
by: Wei Wang, et al.
Published: (2025-01-01)

Disruption of erythroid nuclear opening and histone release in myelodysplastic syndromes
by: Baobing Zhao, et al.
Published: (2019-03-01)

STAT signaling in the pathogenesis and therapy of acute myeloid leukemia and myelodysplastic syndromes
by: Zoe King, et al.
Published: (2025-03-01)

Acute Myeloid Leukemia with Basophilic Differentiation Transformed from Myelodysplastic Syndrome
by: Yasuhiro Tanaka, et al.
Published: (2017-01-01)

Sodium-glucose co-transporter-2 inhibitor treatment-associated changes in hemoglobin level in anemic patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms
by: Ali Alsugair, et al.
Published: (2025-01-01)

Translocation (6;15)(q12;q15): A Novel Mutation in a Patient with Therapy-Related Myelodysplastic Syndrome
by: Saba F. Ali, et al.
Published: (2015-01-01)

Acquired Elliptocytosis as a Manifestation of Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia
by: Jacob D. Kjelland, et al.
Published: (2017-01-01)

Pulmonary Complications of Azanucleoside Therapy in Patients with Myelodysplastic Syndrome and Acute Myelogenous Leukemia
by: Manuel Molina, et al.
Published: (2015-01-01)

Phenotypic and Cytogenetic Characterization of Mesenchymal Stromal Cells in De Novo Myelodysplastic Syndromes
by: A. J. I. S. Rathnayake, et al.
Published: (2016-01-01)

Acquired Elliptocytosis as a Manifestation of Myelodysplastic Syndrome Associated with Deletion of Chromosome 20q
by: Sukesh Manthri, et al.
Published: (2018-01-01)

The AST/ALT (De Ritis) ratio as a significant prognostic factor in myelodysplastic syndrome
by: Ying Chen, et al.
Published: (2024-12-01)

Successful Treatment of Myeloid Sarcoma in an Elderly Patient with Myelodysplastic Syndrome with Reduced-Dose Azacitidine
by: Kazuya Sato, et al.
Published: (2021-01-01)

Gambaran Hematologi Pasien Myelodysplastic Syndrome di RSUP Dr. M. Djamil Padang
by: Bestri Neli Agustin, et al.
Published: (2019-09-01)

Bi-targeting of thioredoxin 1 and telomerase by thiotert promotes cell death of myelodysplastic syndromes and lymphoma
by: Qiangan Jing, et al.
Published: (2025-01-01)

Red Blood Cell Transfusion Independence Following the Initiation of Iron Chelation Therapy in Myelodysplastic Syndrome
by: Maha A. Badawi, et al.
Published: (2010-01-01)

Higher Risk Myelodysplastic Syndromes in Patients with Well-Controlled HIV Infection: Clinical Features, Treatment, and Outcome
by: Bradley T. Williamson, et al.
Published: (2016-01-01)

The role of the CLL-1 protein in disease monitoring in patients diagnosed with acute myeloid leukaemia and myelodysplastic syndrome
by: Ewa Dobak, et al.
Published: (2024-10-01)

EZH2 inhibition induces pyroptosis via RHA-mediated S100A9 overexpression in myelodysplastic syndromes
by: Qi Zhang, et al.
Published: (2025-01-01)

Decitabine-Induced Changes in Human Myelodysplastic Syndrome Cell Line SKM-1 Are Mediated by FOXO3A Activation
by: Wen Zeng, et al.
Published: (2017-01-01)

HAPLOIDENTICAL TRANSPLANT WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE FOR ACUTE MYELOID LEUKAEMIA AND MYELODYSPLASTIC SYNDROMES PATIENTS: THE ROLE OF PREVIOUS LINES OF THERAPY.
by: Daniele Avenoso, et al.
Published: (2024-01-01)

Dysregulation of transposable elements and PIWI-interacting RNAs in myelodysplastic neoplasms
by: Zdenek Krejcik, et al.
Published: (2025-01-01)

Increased Circulating CD4+CXCR5+ Cells and IgG4 Levels in Patients with Myelodysplastic Syndrome with Autoimmune Diseases
by: Na Xiao, et al.
Published: (2021-01-01)

Astragalin: A Bioactive Phytochemical with Potential Therapeutic Activities
by: Ammara Riaz, et al.
Published: (2018-01-01)

A Paraneoplastic Syndrome Characterized by Extremity Swelling with Associated Inflammatory Infiltrate Heralds Aggressive Transformation of Myelodysplastic Syndromes/Myeloproliferative Neoplasms to Acute Myeloid Leukemia: A Case Series
by: James K. Mangan, et al.
Published: (2012-01-01)

Melanin-like nanoparticles as a potential novel therapeutic approach in ADPKD
by: Laura Cassina, et al.
Published: (2024-11-01)

Novel Therapeutic Approaches to the Treatment of Chronic Abdominal Visceral Pain
by: Franca Patrizi, et al.
Published: (2006-01-01)

Elucidating the Role of the T Cell Receptor Repertoire in Myelodysplastic Neoplasms and Acute Myeloid Leukemia
by: Georgios Petros Barakos, et al.
Published: (2025-01-01)

Iron overload impact on peripheral blood cells, lymphocytes and karyotypes in newly diagnosed myelodysplastic syndromes (MDS) patients: a single-center retrospective analysis
by: Lixiang Duan, et al.
Published: (2024-12-01)

Characteristics and outcomes of patients with lymphoma who developed therapy-related acute myeloid leukemia or myelodysplastic syndrome – a retrospective analysis of the Polish Adult Leukemia Group
by: Aleksandra Gołos, et al.
Published: (2024-07-01)

Psychometric properties and meaningful change thresholds for the QOL-E instrument in patients with myelodysplastic neoplasms
by: Esther Natalie Oliva, et al.
Published: (2025-02-01)

Oligonucleotides as a Novel Therapeutic Approach: An Innovative Area for Drug Delivery in Neurological Disorders
by: Yasir Qasim Almajidi, et al.
Published: (2025-01-01)